葛蘭素史克是英國的一家制藥、生物以及醫療保健公司，是世界第二大的制藥公司。葛蘭素威康由葛蘭素實驗室和寶來威康合并而成，而葛蘭素史克由葛蘭素威康和史克必成合并而成。2000年，它得名葛蘭素史克并以GSK而周知。GSK在117個國家有約110,000位員工，其中超過40,000參與營銷環節。極少的全球總部在倫敦布倫特福德，英國和美國外。而倫敦和紐約證券交易所都把GSK列入在內。一些著名的品牌，如利賓納（飲料），必理痛善胃得（抗潰瘍），舒維療（抗病毒），（鎮痛）以及沃格孟汀（抗生素）都經他們銷售。
 

宗旨：
 

葛蘭素史克（GSK）致力于通過指導人們做得更多，感覺更好，活得更長，以此來提高人們生活質量。
 

此外，GSK承擔著積極的企業精神。這是受其不斷追求研究創新所啟發的。葛蘭素史克關注績效，這也使他們充分實現作為一個世界級的全球領先者對迫切成功的無與倫比的激情。

 

GlaxoSmithKline is a UK based pharmaceutical, biological and healthcare company. It is the world’s second largest pharmaceutical company. Glaxo Wellcome, which is formed from the merger of Glaxo Laboratories and Burroughs Wellcome & Company, together with the SmithKline Beecham and they have form the GlaxoSmithKline. In the year 2000, GlaxoSmithKline have the name and known as GSK. GSK had employs around 110,000 workers in 117 countries, and is including over 40,000 that participate in sales and marketing. There are few global headquarters which is separated in GSK House in Brebtfort, London, United Kingdom and United States. The London and New York stock exchanges have listed the GSK Company in their list. Some well known brands such as Ribena (beverage), Panadol Zantac (anti-ulcer), Zavirax (anti-viral), (pain relief) and Augmentin (antibiotic) which is selling by them.

 

宗旨---Mission statement:
 

The GlaxoSmithKline (GSK) global quest is to improve the quality of human life by guiding people to do more, to let them feel better, and also live longer.

 

Besides that, the GSK has to undertake the entrepreneurial spirit of enthusiasm. It is inspired by the constant search for the pursuit of innovation. GlaxoSmithKline attention to performance also made their complete realization and each and every citizen, as a global leader in world-class and unparalleled passion for the success of awareness contribute to the sense of urgency. In addition, two have been entered into by the diversity of life and set statements declaration statements.

 

多樣性保證---Diversity Statement:
 

GlaxoSmithKline provides an employee with respect and dignity for all working towards the environment diverse workforce. With different backgrounds, cultures and world views of the labour force to help it understand the different patients, but also the needs of customers. GlaxoSmithKline in the right positions to ensure that they do the best to provide genuine equality of opportunity best work. It can monitor and manage the level and then around the world, the report by the UK ethnic and gender diversity on the data, to ensure compliance with the commitment to diversity.

 

使命宣言---Life Statement:
 

GSK committed to the hope that all workers can do their best work. The way they do, not only to meet the business, but for your own personal needs and need it.

 

That is why they attach so much importance to flexible working. GlaxoSmithKline is to support flexible working arrangements, as long as it can make a better life for employees, while ensuring that business needs are met. Flexible work policies, applicable to all staff, and it covers several modes of operation, for example, like home work, part-time jobs, annual hours, but also long-time work. In addition, the types of flexible working options are particularly attractive to parents and caregivers. However, the reduction or re-allocation of time or home-working arrangements can also support people's religious observances. It is there along with all other interests and responsibilities outside the workplace of the host.

 

GSK價值及其運行狀況---GSK Values and Behaviours
 

Health care market in the past decade there is a need to change our business model into a more customer-centric, innovative how we perform as a collective organization, will determine our success. To the external environment with increasingly complex and effective changes in speed index, GlaxoSmithKline need to establish an internal learning culture by GlaxoSmithKline reflect the values and behaviour.
 

	Sales ($ m)	Operating Profit ($ m)	Net Profit ($ m)	Total Assets ($ m)	Diluted earnings per share ($)	Number of Employees
2009	28,368	8,425	5,669	42,862	108.20	99,000
2008	24,352	7,141	4,712	39,393	88.10	99,003
2007	22,716	7,593	5,310	31,003	93.70	103,483
2006	23,225	7,808	5,498	25,553	94.50	102,695
2005	21,660	6,874	4,816	--	82.00	100,728

 

Figure 1.0

 

As a 2nd largest pharmaceutical company, GSK financial should be doing well in their financial to maintain the images and reputation of the company. Well, to increase its market competitiveness, GSK need to have stable profits to run the research and future development.

 

According to the table above we can understand the financial summary of GSK in year 2005 to year 2009. First we can see that the total revenue in year 2005 to 2009 is performing well. But the total revenue of year 2005 and 2006 is remaining the same while in year 2007 is decreasing and it increase back when year 2008 and 2009 as well. The total revenue amount of year 2005 is £21660 million and 2006 is £23225 million. The years 2005 to year 2006 it has 7.23% increase in the company. And by the year 2007 it decrease to amount of £22716 million, which is reducing about £509 million, about 2.192% decrease compare to year 2006. In the year 2008 it increases £1636 million back to amount of £24352 million, which the percentage is 7.202%. And in between year 2008 to 2009 it increase £4016 million to amount of £28368 million which the percentage is 16.491%.

 

figure 1.1
 

Environmental Analysis (PESTLE分析)
 

Technological advancements, tighter regulatory-compliance overheads, rafts of patent expiries and volatile investor confidence have made the modern pharmaceutical industry an increasingly tough and competitive environment. Below is an analysis of the structure of the pharmaceutical industry using the PESTLE which mean political, economic, social and technological, and legal environment.

 

Political:

 

Over the years, the industry has witnessed increased political attention due to the increased the recognition of the economic importance of healthcare as a component of social welfare. Political interest has also been generated because of the increasing social and financial burden of healthcare. Examples are the UK’s National Health Service debate and Medicare in the US.

 

Economic:

 

In the decade to 2003 the pharmaceutical industry witnessed high value mergers and

 

Acquisitions 7 with a projected stock value growth rate of 10.5% (2003-2010) and Health Care. Growth rate of 12.5% (2003-2010), the audited value of the global pharmaceutical market is estimated to reach a huge 500 billion dollars by 2004. Only information technology has a higher expected growth rate of 12.6%. Majority of pharmaceutical sales originate in the US, EU and Japanese markets. Nine geographic markets account for over 80% of global pharmaceutical sales these are, US, Japan, France, Germany, UK, Italy, Canada, Brazil and Spain. Of these markets, the US is the fastest growing market and since 1995 it has accounted for close to 60% of global sales. In 2000 alone the US market grew by 16% to $133 billion dollars making it a key strategic market for pharmaceuticals.

 

Social:

 

Good health is an important personal and social requirement and the unique role pharmaceutical firm’s play in meeting society’s need for popular wellbeing cannot be underestimated. In recent times, the impact of various global epidemics likes SARS, AIDS etc has also attracted popular and media attention to the industry. The effect of the intense media and political attention has resulted in increasing industry efforts to create and maintain good government-industry-society communications.

 

Technological:

 

A modern scientific and technological advance in science is forcing industry players to adapt ever faster to the evolving environments in which they participate. Scientific advancements have also increased the need for increased spending on research and development in order to encourage innovation.

 

Legal Environment:

 

Pharmaceutical industry is a highly regulated industry and compliance enforcement. Therefore there are a huge laws, regulations and compliance with the industry indirectly absorbed. This tends to limit its activity, and in recent years, the Government has begun to require regulation of the industry cost of the proposal, in order to avoid obstacles, embedded in the external market, global challenges, in the face of innovation.

 

Market share

 

直接競爭對手比較---Direct Competitor Comparison
 

NVS = Novartis AG

 

PFE = Pfizer Inc.

 

SNY = Sanofi-Aventis

 

Industry = Drug Manufacturers - Major

 

Competitor situation

 

One of the main competitors of GSK is Pfizer. Pfizer Inc. is a U.S. listed global biopharmaceutical company. Founded in 1849, the company is headquartered in New York City, in Groton research, based in Connecticut. It is engaged in the discovery, development, manufacturing, and global human and animal prescription drug market, currently sells the second-largest pharmaceutical company.

 

Its main products include devices for blood, high blood pressure and cardiovascular events Caduet Pfizer's Lipitor cholesterol levels. Pfizer and its subsidiaries employ approximately 116,500 people worldwide. The company is among the world top 500, ranking No. 40 in 2010, and the most recent dollar price of 68.0bn acquisition of Wyeth Pharmaceuticals Company. In 2009, Pfizer reported revenues of 50.0bn and an operating profit of £12.1bn and £7.8bn was invested in R&D.

 

葛蘭素史克SWOT分析---GlaxoSmithKline SWOT
 

Strengths
 

Reputation management 

 

large market share

 

large highly skilled work force 

 

Globally positioned 

 

2nd largest in the pharmaceutical industry

 

Weaknesses
 

No online presence

 

Inconsistency of attractive promotions

 

High dependency on only several products

 

Strong focus on UK market

 

Opportunities
 

New drug development

 

Organic growth

 

Licensing

 

Threats
 

Rising drug cost

 

Drug side effect

 

competition SWOT stands for strength, weakness, opportunity and threats The rationale for conducting a SWOT analysis before proceeding to the development of the strategic plan is to know whether the organization's plan is a good fit for its internal and external situation or not. An organization's internal situation is defined by its strengths and weaknesses. An organization's external situation is defined by its opportunities and threats that exist in the business environment

 

輝瑞SWOT分析---Pfizer SWOT analysis
 

Strengths
 

Strong sales and marketing infrastructure

 

Strong R&D departments

 

Marketing strength in major geographical and therapeutic areas

 

Weaknesses
 

Very limited penetration of biologics market

 

Discontinuation of products in the latter stages of development

 

Co-marketing agreements can limit Pfizer's global presence

 

Opportunities
 

Funding available to facilitate product

 

Biologic market expansion

 

Emergence of integrated global markets and globalisation for new products

 

Strengths, providing Pfizer with strong products and therefore revenue growth

 

Threats
 

which is Lipitor, due to lose patent exclusivity in 2011

 

Further large scale M&A activity could further decline Pfizer's profitability

 

An increase in the number of safety issues surrounding Viagra

 

Economic downturn influencing consumers' purchasing power

 

For the price of the microprocessor produce by Intel and AMD, the difference of the performance actually not very big there is just a small different of the performance, but AMD able to sell their product with a cheapest price compare to Intel but at the same AMD having a very big problem which is their product quality is not that stable, it might not be long lasting compare to Intel and Intel having a partnership with Microsoft company and this is another advantage that the buyers of Intel processor would not need to purchase operating system for their computer compare to AMD which the buyers need to purchase another operating system from Microsoft or Mac by themselves. The opportunities of Intel actually is the dominance of the market share in the market, they having a lots of different customer around the world unlike AMD which only having a little section of the market share while they lost a little of the customer will having a difficulty of the company operating due to the lack of financial power, but at the same time AMD having a growth on the market share and they might grab some of the market share due to the unstable demand of the market towards microprocessor and while they grab the market share will lead to the loss of Intel market share in microprocessor market.

 

Smart objective

 

Objective for branding and promotional

 

Specific

 

Increase more healthy drinks like Horlicks and Ribena that has no artificial colour, flavour and sweetener

 

Having more outlet to sell the healthy product in hypermarket

 

Create more advertisement about GSK healthy drinks product

 

Measurable

 

sells more than 120 million bottles of drinks each year

 

by the year 2013, become one of the largest healthy drinks company in market

 

Achievable

 

Services developed and developing countries to improve people's quality of life

 

enabling people to do more to improve the quality of life of people

 

Realistic

 

provide the good service and the high quality of product

 

increase public trust and to let consumers feel that it is worth and they are willing to buy the product

 

Timely

 

In 3 years time, recognize by community as providing the healthy product company

 

Environmental

 

Objective for growth

 

Specific

 

Become the environmental friendly company

 

Have more advertisement about recycle and educate the consumer and make resources available for them.

 

Measurable

 

Having 0% of industrial waste

 

Producing 100% recycle product from company

 

Achievable

 

Let public and user know more about recycle product

 

Research and develop more recycle and reuse product

 

Realistic

 

Become one of the best and largest product recycle company in the world

 

Timely

 

In year 2012, company are fully environmental friendly

 

Financial

 

Specific

 

Increase and improve the sales in UK

 

Having an improvement in total revenue and profit of the company

 

Measurable

 

Increase 5% of sales compare to the previous year

 

Achievable

 

Producing new product to influence and increase the purchasing of consumers of our product

 

Realistic

 

Facing so many competitors, product packaging and convenient of having the product, good services should be there to attract customers. So, an increment of 5% in revenue should not be a problem.

 

Timely

 

In year 2012, increase the sales and revenue by 5% and remain increase 5% year by year.

 

GSK is focused on delivering three strategic priorities to transform into a company that delivers more growth that has less risk and an improved long-term financial performance. To be a successful and sustainable business, GSK also fulfils the social responsibilities. By doing this GSK is seen like more responsive, more flexible and more open.

 

三項戰略重點---Three Strategic priorities
 

The first priority of GSK is “growing a diversified global business”. GSK diversifying its business to create a balanced product portfolio, in the same time move away from reliance on traditional like white pill or western markets. Besides that, GSK also investing in key growth areas such as Emerging Markets, Japan, Vaccines and the Consumer Healthcare business.

 

Next, the second priority is “delivering more products of value”. It aims to sustain in an industry leading pipeline of products, this is to ensuring that they demonstrate value for healthcare providers. The R&D strategy is built around to focusing on the best science which diversifying through externalisation of research and also improving the returns on investment.

 

The last priority is “simplifying the operating model”. GSK is a large and complex organisation which is transforming the operating model to reduce the complexities, to improve efficiency and also reducing the costs.

 

The marketing mix strategy which need 4P (Product, Price, Place, Promotion) to make the market decision, actually is the best strategy to be used on the company in the industry.

 

Product

 

Horlicks is considered one of GSK’s main brands in the health food segment. Due to slow profit made in health products of Horlicks, the company has come up with strategies to push the flagship of the brand. Horlicks has previously target old people as a nourishment health drink for, but now they are re-launching its brand and targeting children in the market. GSK is expecting Horlicks to have an increase in turnover of health food sector. Horlicks has relaunched new products that are now available in the market such as Chocolate, Creamy Vanilla and Honey Buzz varieties in package that not only tickles the taste bud of children but also providing nutrients for the health and growth of children such as Vitamin A, Proteins, Carbohydrate and so on.

 

A fresh new image for Horlicks

 

Price

 

Horlick has white and brown drinks, where the white drink is for entire family and the brown drink focuses on children. White drink has a faster growth rate and this has added the benefits of enhancing the healthy image of Horlicks. This does not mean the target market of children has left unattended. Horlicks now positioned as a nourishment drink targeting children of age group between 8-14. Children nowadays have huge influence on things that family members buy, and therefore Horlicks prefer children to purchase their health drinks. Horlicks has also come up with products that that target kids between one and three.

 

Place

 

In UK, Horlicks already is a very famous product which able to found in every hypermarket, mini market in UK. Other than that, it also can be found in all the convenience stores. Besides that, the main wholesalers distribute products, so small shops within easy reach of local grain through the cash and carry.

 

Promotion

 

In order to increase consumer awareness of the brand of Horlicks, GSK can promote the product through TV advertisement, radio advertisement. Besides that, it also can advertise in the cinema before a movie or having a banner on the internet. On the other hand, we can also having free gift of Horlicks product by giving through the radio when the audience answer one question about Horlicks.

 

預測及暗示---Forecast and Implication
 

3-years forecast and budget

 

	Sales (￡mil)	Cost	Profit
2009	28368	3370.5	509
2010	6273.75	3539.03	534.45
2011	6587.44	3715.98	561.17
2012	6916.81		589.23